Taping and Patellar Maltraction in PFPS Patients
Launched by ANKARA YILDIRIM BEYAZIT UNIVERSITY · Dec 30, 2020
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
This is a single blinded randomized controlled trial, will be conducted at Ankara Yıldırım Beyazıt UniversityYenimahalle Education and Research Hospital. Evaluations regarding the parameters and inclusion criteria at the stage of diagnosis will be carried out by the Specialist Physician, exercise therapy and taping practices by the Specialist Physiotherapist, and the MRI measurements by the Specialist Radiologist. Fixed probability stratified randomization method will be preferred in order to ensure proportional gender distribution in the formation of groups and participants will be divided...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Presence of anterior knee pain lasting more than 6 weeks
- • Anterior or retropatellar knee pain is present in at least two activities (stair descending, stair climbing, squatting, running, jumping, sitting for a long time
- • Presence of malalignment of patellofemoral joint in MRI examination \[Bisect offset index (BOİ) ≥57 and / or patellar tilt angle (PTA) ≥15\]
- Exclusion Criteria:
- • presence of knee trauma history and/or previous knee surgery
- • presence limitation in knee joint range of motion
- • presence of meniscopathy or lesion in knee ligaments
- • presence of patellar subluxation or dislocation
- • presence of a neuromuscular (upper or lower motor neuron lesions), cardiovascular or rheumatological disease
- • pregnancy status
- • presence of MRI contraindications
About Ankara Yildirim Beyazıt University
Ankara Yıldırım Beyazıt University is a leading academic institution in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its expertise in healthcare and innovative research methodologies to conduct ethical and scientifically rigorous clinical studies. By fostering collaboration among multidisciplinary teams, Ankara Yıldırım Beyazıt University aims to contribute to the development of novel therapies and enhance patient care, while adhering to the highest standards of regulatory compliance and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Ertuğrul Demirdel, PhD
Principal Investigator
Ankara Yildirim Beyazıt University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials